Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Early markers of cardiovascular disease.

Kapuku GK, Harshfield GA, Davis HC, Treiber FA.

Vascul Pharmacol. 2006 Nov;45(5):277-80. Epub 2006 Aug 23. Review.

PMID:
17011834
2.

Assessment of vascular disease using arterial flow mediated dilatation.

Patel S, Celermajer DS.

Pharmacol Rep. 2006;58 Suppl:3-7. Review.

3.

Vascular wall function as a risk marker for cardiovascular disease.

Cohn JN.

J Hypertens Suppl. 1999 Dec;17(5):S41-4. Review.

PMID:
10706325
4.

Endothelial cell dysfunction and arterial wall hypertrophy are associated with disturbed carbohydrate metabolism in patients at risk for cardiovascular disease.

Thalhammer C, Balzuweit B, Busjahn A, Walter C, Luft FC, Haller H.

Arterioscler Thromb Vasc Biol. 1999 May;19(5):1173-9.

5.
6.

Prenatal testosterone induces sex-specific dysfunction in endothelium-dependent relaxation pathways in adult male and female rats.

Chinnathambi V, Yallampalli C, Sathishkumar K.

Biol Reprod. 2013 Oct 24;89(4):97. doi: 10.1095/biolreprod.113.111542. Print 2013 Oct.

7.

Exploring vascular benefits of endothelium-derived nitric oxide.

Cockcroft JR.

Am J Hypertens. 2005 Dec;18(12 Pt 2):177S-183S. Review.

PMID:
16373196
8.

Disruption of Physiological Balance Between Nitric Oxide and Endothelium-Dependent Hyperpolarization Impairs Cardiovascular Homeostasis in Mice.

Godo S, Sawada A, Saito H, Ikeda S, Enkhjargal B, Suzuki K, Tanaka S, Shimokawa H.

Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):97-107. doi: 10.1161/ATVBAHA.115.306499. Epub 2015 Nov 5.

9.
10.

Insulin resistance predicts endothelial dysfunction and cardiovascular risk in HIV-infected persons on long-term highly active antiretroviral therapy.

Mondy KE, de las Fuentes L, Waggoner A, Onen NF, Bopp CS, Lassa-Claxton S, Powderly WG, Dávila-Román V, Yarasheski KE.

AIDS. 2008 Apr 23;22(7):849-56. doi: 10.1097/QAD.0b013e3282f70694.

11.

New molecular mechanisms for cardiovascular disease: contribution of endothelium-derived hyperpolarizing factor in the regulation of vasoconstriction in peripheral resistance arteries.

Jin X, Satoh-Otonashi Y, Zamami Y, Takatori S, Hashikawa-Hobara N, Kitamura Y, Kawasaki H.

J Pharmacol Sci. 2011;116(4):332-6. Epub 2011 Jul 14. Review.

12.

[Asymmetric dimethylarginine--a novel cardiovascular risk factor].

Siroká R, Cibulka R, Rajdl D, Racek J.

Vnitr Lek. 2006 Mar;52(3):249-55. Review. Czech.

PMID:
16722156
13.

Apolipoprotein B of low-density lipoprotein impairs nitric oxide-mediated endothelium-dependent relaxation in rat mesenteric arteries.

Zhang Y, Zhang W, Edvinsson L, Xu CB.

Eur J Pharmacol. 2014 Feb 15;725:10-7. doi: 10.1016/j.ejphar.2014.01.008. Epub 2014 Jan 18.

PMID:
24444440
14.

Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter?

Green DJ, Jones H, Thijssen D, Cable NT, Atkinson G.

Hypertension. 2011 Mar;57(3):363-9. doi: 10.1161/HYPERTENSIONAHA.110.167015. Epub 2011 Jan 24. Review.

15.

Endothelial dysfunction and arterial pressure regulation during early diabetes in mice: roles for nitric oxide and endothelium-derived hyperpolarizing factor.

Fitzgerald SM, Kemp-Harper BK, Parkington HC, Head GA, Evans RG.

Am J Physiol Regul Integr Comp Physiol. 2007 Aug;293(2):R707-13. Epub 2007 May 23.

16.

Potential of Food and Natural Products to Promote Endothelial and Vascular Health.

Auger C, Said A, Nguyen PN, Chabert P, Idris-Khodja N, Schini-Kerth VB.

J Cardiovasc Pharmacol. 2016 Jul;68(1):11-8. doi: 10.1097/FJC.0000000000000382. Review.

PMID:
26974893
17.

Endothelium-dependent vascular relaxation induced by Globularia alypum extract is mediated by EDHF in perfused rat mesenteric arterial bed.

Chokri A, El Abida K, Zegzouti YF, Ben Cheikh R.

Can J Physiol Pharmacol. 2012 May;90(5):607-16. doi: 10.1139/y2012-035. Epub 2012 Apr 24.

PMID:
22530963
18.

Essential role of nitric oxide in sepsis-induced impairment of endothelium-derived hyperpolarizing factor-mediated relaxation in rat pulmonary artery.

Subramani J, Leo MD, Kathirvel K, Arunadevi R, Singh TU, Prakash VR, Mishra SK.

Eur J Pharmacol. 2010 Mar 25;630(1-3):84-91. doi: 10.1016/j.ejphar.2009.12.026. Epub 2009 Dec 24.

PMID:
20035746
19.
20.

Venous or arterial endothelium evaluation for early cardiovascular dysfunction in hypertensive patients?

Rubira MC, Consolim-Colombo FM, Rabelo ER, Yugar-Toledo JC, Casarini D, Coimbra SR, Martins LC, Moreno H Jr, Krieger EM, Irigoyen MC.

J Clin Hypertens (Greenwich). 2007 Nov;9(11):859-65.

Supplemental Content

Support Center